Skip to main content
Premium Trial:

Request an Annual Quote

BioSolutions, Bioquote Reach Distribution Deal for UK, Ireland

NEW YORK (GenomeWeb News) – Claremont BioSolutions today announced a distribution deal with Bioquote covering the UK and Ireland.

The deal is for Claremont's products for sample preparation, DNA isolation, and protein purification and extends the Upland, Calif.-based company's reach into Europe. The first product to be marketed will be the company's Omnilyse lysis kits and PureLyse extraction kits.

Claremont develops, manufactures, and markets cell lysis, DNA extraction, and His-tagged protein purification kits and columns. Bioquote, headquartered in York, UK, distributes life science products throughout Europe.

Financial and other terms of the deal were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.